GASTROINTESTINAL TUMORS : Impact Factor & More
eISSN: 2296-3766pISSN: 2296-3774
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on GASTROINTESTINAL TUMORS
GASTROINTESTINAL TUMORS Journal Specifications
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 900 | USD 1040 | CHF 950 |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in GASTROINTESTINAL TUMORS ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in GASTROINTESTINAL TUMORS
Tumor-associated macrophage density as a predictive biomarker for survival benefit from adjuvant chemotherapy in gastric cancer
- 1 Jan 2026
- Gastrointestinal Tumors
A case of synchronous ileocecal adenocarcinoma and plasmacytoma initially presenting with multiple cerebral infarctions
- 1 Jan 2026
- Gastrointestinal Tumors
Synergistic cell death pathways in gastrointestinal tumor immunotherapy: molecular mechanisms, metabolic reprogramming, and clinical translation
- 1 Jan 2026
- Gastrointestinal Tumors
Integrated co-mutation profiling reveals a novel genomic classification for prognostication and tailored therapy in biliary tract cancer
- 1 Jan 2026
- Gastrointestinal Tumors
Clinicopathological features and prognostic significance of SYT8 in patients with colorectal cancer who received curative surgery
- 1 Jan 2025
- Gastrointestinal Tumors
ENO1 regulates trastuzumab resistance in gastric cancer cells through IRP1
- 1 Jan 2025
- Gastrointestinal Tumors
Tumor-associated macrophage density as a predictive biomarker for survival benefit from adjuvant chemotherapy in gastric cancer
- 1 Jan 2026
- Gastrointestinal Tumors
A case of synchronous ileocecal adenocarcinoma and plasmacytoma initially presenting with multiple cerebral infarctions
- 1 Jan 2026
- Gastrointestinal Tumors
Synergistic cell death pathways in gastrointestinal tumor immunotherapy: molecular mechanisms, metabolic reprogramming, and clinical translation
- 1 Jan 2026
- Gastrointestinal Tumors
Integrated co-mutation profiling reveals a novel genomic classification for prognostication and tailored therapy in biliary tract cancer
- 1 Jan 2026
- Gastrointestinal Tumors
Clinicopathological features and prognostic significance of SYT8 in patients with colorectal cancer who received curative surgery
- 1 Jan 2025
- Gastrointestinal Tumors
ENO1 regulates trastuzumab resistance in gastric cancer cells through IRP1
- 1 Jan 2025
- Gastrointestinal Tumors
FAQs on GASTROINTESTINAL TUMORS
How long has GASTROINTESTINAL TUMORS been actively publishing? 
What is the publishing frequency of GASTROINTESTINAL TUMORS?
How many articles did GASTROINTESTINAL TUMORS publish last year?
What is the eISSN & pISSN for GASTROINTESTINAL TUMORS?
Who is the publisher of GASTROINTESTINAL TUMORS?
